Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Larsson Callerfelt, Anna Karin ^a   Hallgren, Oskar ^a,b   Andersson Sjöland, Annika ^a   Thiman, Lena ^a   Björklund, Johan ^a   Kron, Josefine ^a   Nihlberg, Kristian ^a   Bjermer, Leif ^b   Löfdahl, Claes Göran ^b   Westergren Thorsson, Gunilla ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Biglycan; Chronic obstructive pulmonary disease; Collagen I; Decorin; Fibroblast; Fibroblast gel contraction; Proliferation; Prostacyclin; Proteoglycans; Transforming growth factor

Indexed keywords

BIGLYCAN; COLLAGEN TYPE 1; DECORIN; GLUCOCORTICOID; ILOPROST; PROSTACYCLIN; TRANSFORMING GROWTH FACTOR BETA1; BGN PROTEIN, HUMAN; DCN PROTEIN, HUMAN; TGFB1 PROTEIN, HUMAN;

ADULT; ARTICLE; ATTENUATION; CELL MIGRATION; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG BIOPSY; LUNG FIBROBLAST; LUNG TRANSPLANTATION; MALE; TRANSBRONCHIAL BIOPSY; BIOPSY; CASE CONTROL STUDY; CELL CULTURE; CELL MOTION; DRUG EFFECT; FIBROBLAST; LUNG; METABOLISM; PATHOLOGY; PHENOTYPE;

ADULT; BIGLYCAN; BIOPSY; CASE-CONTROL STUDIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN TYPE I; DECORIN; EPOPROSTENOL; FEMALE; FIBROBLASTS; HUMANS; ILOPROST; LUNG; MALE; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TRANSFORMING GROWTH FACTOR BETA1; YOUNG ADULT;

EID: 84873583925     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-21     Document Type: Article

References (51)

1. Postma DS, Timens W. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:434-439. 10.1513/pats.200601-006AW, 16799088.
2. Siafakas NM, Antoniou KM, Tzortzaki EG. Role of angiogenesis and vascular remodeling in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2007, 2:453-462. 2699970, 18268919.
3. Barbera JA, Blanco I. Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management. Drugs 2009, 69:1153-1171. 10.2165/00003495-200969090-00002, 19537834.
4. Gessler T, Seeger W, Schmehl T. Inhaled prostanoids in the therapy of pulmonary hypertension. J Aerosol Med Pulm Drug Deliv 2008, 21:1-12. 10.1089/jamp.2007.0657, 18518827.
5. Dernaika TA, Beavin M, Kinasewitz GT. Iloprost improves gas exchange and exercise tolerance in patients with pulmonary hypertension and chronic obstructive pulmonary disease. Respiration 2010, 79:377-382. 10.1159/000242498, 19786728.
6. Hegewald MJ, Elliott CG. Sustained improvement with iloprost in a COPD patient with severe pulmonary hypertension. Chest 2009, 135:536-537. 10.1378/chest.08-1515, 19201716.
7. Moncada S, Higgs EA, Vane JR. Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation. Lancet 1977, 1:18-20.
8. Coleman RA, Smith WL, Narumiya S. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994, 46:205-229.
9. Stratton R, Shiwen X, Martini G, Holmes A, Leask A, Haberberger T, Martin GR, Black CM, Abraham D. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001, 108:241-250. 203022, 11457877.
10. Kohyama T, Liu X, Kim HJ, Kobayashi T, Ertl RF, Wen FQ, Takizawa H, Rennard SI. Prostacyclin analogs inhibit fibroblast migration. Am J Physiol Lung Cell Mol Physiol 2002, 283:L428-432.
11. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004, 364:709-721. 10.1016/S0140-6736(04)16900-6, 15325838.
12. Westergren-Thorsson G, Larsen K, Nihlberg K, Andersson-Sjoland A, Hallgren O, Marko-Varga G, Bjermer L. Pathological airway remodelling in inflammation. Clin Respir J 2010, 4(Suppl 1):1-8.
13. Fine A, Poliks CF, Smith BD, Goldstein RH. The accumulation of type I collagen mRNAs in human embryonic lung fibroblasts stimulated by transforming growth factor-beta. Connect Tissue Res 1990, 24:237-247. 10.3109/03008209009152152, 2376126.
14. Polgar P, Taylor L. Alterations in prostaglandin synthesis during senescence of human lung fibroblasts. Mech Ageing Dev 1980, 12:305-310. 10.1016/0047-6374(80)90063-9, 6993800.
15. Cruz-Gervis R, Stecenko AA, Dworski R, Lane KB, Loyd JE, Pierson R, King G, Brigham KL. Altered prostanoid production by fibroblasts cultured from the lungs of human subjects with idiopathic pulmonary fibrosis. Respir Res 2002, 3:17. 10.1186/rr166, 107846, 11980586.
16. Lovgren AK, Jania LA, Hartney JM, Parsons KK, Audoly LP, Fitzgerald GA, Tilley SL, Koller BH. COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2006, 291:L144-156. 10.1152/ajplung.00492.2005, 16473862.
17. Hallgren O, Nihlberg K, Dahlback M, Bjermer L, Eriksson LT, Erjefalt JS, Lofdahl CG, Westergren-Thorsson G. Altered fibroblast proteoglycan production in COPD. Respir Res 2010, 11:55. 10.1186/1465-9921-11-55, 2886021, 20459817.
18. Hallgren O, Rolandsson S, Andersson-Sjoland A, Nihlberg K, Wieslander E, Kvist-Reimer M, Dahlback M, Eriksson L, Bjermer L, Erjefalt J. Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients. J Transl Med 2012, 10:171. 10.1186/1479-5876-10-171, 3477051, 22913419.
19. Nihlberg K, Andersson-Sjoland A, Tufvesson E, Erjefalt JS, Bjermer L, Westergren-Thorsson G. Altered matrix production in the distal airways of individuals with asthma. Thorax 2010, 65:670-676. 10.1136/thx.2009.129320, 20685740.
20. Tufvesson E, Westergren-Thorsson G. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha. J Cell Biochem 2000, 77:298-309. 10.1002/(SICI)1097-4644(20000501)77:2<298::AID-JCB12>3.0.CO;2-D, 10723095.
21. Tiedemann K, Malmstrom A, Westergren-Thorsson G. Cytokine regulation of proteoglycan production in fibroblasts: separate and synergistic effects. Matrix Biol 1997, 15:469-478. 10.1016/S0945-053X(97)90020-2, 9106158.
22. Tufvesson E, Malmstrom J, Marko-Varga G, Westergren-Thorsson G. Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts. Eur J Biochem 2002, 269:3688-3696. 10.1046/j.1432-1033.2002.03058.x, 12153565.
23. Westergren-Thorsson G, Sarnstrand B, Fransson LA, Malmstrom A. TGF-beta enhances the production of hyaluronan in human lung but not in skin fibroblasts. Exp Cell Res 1990, 186:192-195. 10.1016/0014-4827(90)90227-2, 2298235.
24. Gillies RJ, Didier N, Denton M. Determination of cell number in monolayer cultures. Anal Biochem 1986, 159:109-113. 10.1016/0003-2697(86)90314-3, 3812988.
25. Westergren-Thorsson G, Persson S, Isaksson A, Onnervik PO, Malmstrom A, Fransson LA. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp Cell Res 1993, 206:93-99. 10.1006/excr.1993.1124, 7683278.
26. Larsen K, Tufvesson E, Malmstrom J, Morgelin M, Wildt M, Andersson A, Lindstrom A, Malmstrom A, Lofdahl CG, Marko-Varga G. Presence of activated mobile fibroblasts in bronchoalveolar lavage from patients with mild asthma. Am J Respir Crit Care Med 2004, 170:1049-1056. 10.1164/rccm.200404-507OC, 15256392.
27. Gullberg D, Tingstrom A, Thuresson AC, Olsson L, Terracio L, Borg TK, Rubin K. Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF. Exp Cell Res 1990, 186:264-272. 10.1016/0014-4827(90)90305-T, 2298242.
28. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008, 178:248-260. 10.1164/rccm.200706-929OC, 2542423, 18467512.
29. Coker RK, Laurent GJ. Pulmonary fibrosis: cytokines in the balance. Eur Respir J 1998, 11:1218-1221. 10.1183/09031936.98.11061218, 9657557.
30. Kokturk N, Tatlicioglu T, Memis L, Akyurek N, Akyol G. Expression of transforming growth factor beta1 in bronchial biopsies in asthma and COPD. J Asthma 2003, 40:887-893. 10.1081/JAS-120023580, 14736088.
31. Stoll P, Wuertemberger U, Bratke K, Zingler C, Virchow CJ, Lommatzsch M. Stage-dependent association of BDNF and TGF-beta1 with lung function in stable COPD. Respir Res 2012, 13:116. 10.1186/1465-9921-13-116, 3561140, 23245944.
32. van Straaten JF, Coers W, Noordhoek JA, Huitema S, Flipsen JT, Kauffman HF, Timens W, Postma DS. Proteoglycan changes in the extracellular matrix of lung tissue from patients with pulmonary emphysema. Mod Pathol 1999, 12:697-705.
33. Krimmer DI, Burgess JK, Wooi TK, Black JL, Oliver BG. Matrix proteins from smoke-exposed fibroblasts are pro-proliferative. Am J Respir Cell Mol Biol 2012, 46:34-39. 10.1165/rcmb.2010-0426OC, 21778414.
34. Noordhoek JA, Postma DS, Chong LL, Menkema L, Kauffman HF, Timens W, van Straaten JF, van der Geld YM. Different modulation of decorin production by lung fibroblasts from patients with mild and severe emphysema. COPD 2005, 2:17-25. 10.1081/COPD-200050678, 17136957.
35. Jackson BA, Goldstein RH, Roy R, Cozzani M, Taylor L, Polgar P. Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture. Biochem Biophys Res Commun 1993, 197:1465-1474. 10.1006/bbrc.1993.2642, 8280164.
36. Van Ly D, Burgess JK, Brock TG, Lee TH, Black JL, Oliver BG. Prostaglandins but not leukotrienes alter extracellular matrix protein deposition and cytokine release in primary human airway smooth muscle cells and fibroblasts. Am J Physiol Lung Cell Mol Physiol 2012, 303:L239-250. 10.1152/ajplung.00097.2012, 22637153.
37. Zhu Y, Liu Y, Zhou W, Xiang R, Jiang L, Huang K, Xiao Y, Guo Z, Gao J. A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice. Respir Res 2010, 11:34. 10.1186/1465-9921-11-34, 2848635, 20302663.
38. Liu X, Thangavel M, Sun SQ, Kaminsky J, Mahautmr P, Stitham J, Hwa J, Ostrom RS. Adenylyl cyclase type 6 overexpression selectively enhances beta-adrenergic and prostacyclin receptor-mediated inhibition of cardiac fibroblast function because of colocalization in lipid rafts. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:359-369. 10.1007/s00210-007-0196-0, 2665709, 17934720.
39. Yamaguchi Y, Mann DM, Ruoslahti E. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 1990, 346:281-284. 10.1038/346281a0, 2374594.
40. Orgel JP, Eid A, Antipova O, Bella J, Scott JE. Decorin core protein (decoron) shape complements collagen fibril surface structure and mediates its binding. PLoS One 2009, 4:e7028. 10.1371/journal.pone.0007028, 2737631, 19753304.
41. Zandvoort A, Postma DS, Jonker MR, Noordhoek JA, Vos JT, Timens W. Smad gene expression in pulmonary fibroblasts: indications for defective ECM repair in COPD. Respir Res 2008, 9:83. 10.1186/1465-9921-9-83, 2613883, 19087346.
42. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997, 136:729-743. 10.1083/jcb.136.3.729, 2134287, 9024701.
43. Fust A, LeBellego F, Iozzo RV, Roughley PJ, Ludwig MS. Alterations in lung mechanics in decorin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2005, 288:L159-166.
44. Kolb M, Margetts PJ, Sime PJ, Gauldie J. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 2001, 280:L1327-1334.
45. Vlahos R, Wark PA, Anderson GP, Bozinovski S. Glucocorticosteroids differentially regulate MMP-9 and neutrophil elastase in COPD. PLoS One 2012, 7:e33277. 10.1371/journal.pone.0033277, 3296684, 22413009.
46. Kitahara M, Ichikawa M, Kinoshita T, Shiozawa S, Shigematsu H, Komiyama A. Prostacyclin inhibits the production of MMP-9 induced by phorbol ester through protein kinase A activation, but does not affect the production of MMP-2 in Human cultured mesangial cells. Kidney Blood Press Res 2001, 24:18-26. 10.1159/000054201, 11174002.
47. Chen Y, Hanaoka M, Chen P, Droma Y, Voelkel NF, Kubo K. Protective effect of beraprost sodium, a stable prostacyclin analog, in the development of cigarette smoke extract-induced emphysema. Am J Physiol Lung Cell Mol Physiol 2009, 296:L648-656. 10.1152/ajplung.90270.2008, 19201816.
48. Kamio K, Liu X, Sugiura H, Togo S, Kobayashi T, Kawasaki S, Wang X, Mao L, Ahn Y, Hogaboam C. Prostacyclin analogs inhibit fibroblast contraction of collagen gels through the cAMP-PKA pathway. Am J Respir Cell Mol Biol 2007, 37:113-120. 10.1165/rcmb.2007-0009OC, 1899347, 17363776.
49. Noordhoek JA, Postma DS, Chong LL, Vos JT, Kauffman HF, Timens W, van Straaten JF. Different proliferative capacity of lung fibroblasts obtained from control subjects and patients with emphysema. Exp Lung Res 2003, 29:291-302. 10.1080/01902140303789, 12746043.
50. Janssens JP, Pache JC, Nicod LP. Physiological changes in respiratory function associated with ageing. Eur Respir J 1999, 13:197-205. 10.1183/09031936.99.14614549, 10836348.
51. Fukuchi Y. The aging lung and chronic obstructive pulmonary disease: similarity and difference. Proc Am Thorac Soc 2009, 6:570-572. 10.1513/pats.200909-099RM, 19934351.